Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 2.96

(-3.27%)

Operating Income Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual operating income in 2023 was -17.03 Million CNY , up 23.94% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly operating income in 2024 Q3 was -7.44 Million CNY , down -5.84% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported an annual operating income of -22.39 Million CNY in 2022, down -140.04% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported an annual operating income of -9.33 Million CNY in 2021, down -295.06% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly operating income of -7.44 Million CNY for 2024 Q3, down -5.84% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly operating income of -6.43 Million CNY for 2024 Q1, down -67.89% from previous quarter.

Annual Operating Income Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Operating Income of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Operating Income Operating Income Growth
2023 -17.03 Million CNY 23.94%
2022 -22.39 Million CNY -140.04%
2021 -9.33 Million CNY -295.06%
2020 -2.36 Million CNY -114.8%
2019 15.95 Million CNY 37.28%
2018 11.62 Million CNY -74.59%
2017 45.74 Million CNY -36.82%
2016 72.4 Million CNY -1.36%
2015 73.39 Million CNY -37.81%
2014 118 Million CNY 5.54%
2013 111.81 Million CNY 1.25%
2012 110.44 Million CNY 0.0%

Peer Operating Income Comparison of Dali Pharmaceuticalco.,Ltd

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 100.523%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 107.527%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 100.333%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 102.583%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 101.387%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 104.481%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 101.553%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 88.565%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 100.494%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY -905.05%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 100.486%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY 177.297%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 104.23%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 106.838%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 101.25%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY 113.275%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY 190.864%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 101.449%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 101.452%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 104.136%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY 113.989%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY 110.056%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 102.596%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY 117.549%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY 111.707%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 103.022%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 87.403%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 100.552%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 102.997%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY 117.546%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 103.152%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 101.124%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY 109.736%
China National Medicines Corporation Ltd. 2.94 Billion CNY 100.579%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY 119.046%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 103.6%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY 121.005%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 103.046%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 62.704%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 33.392%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 101.905%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 103.174%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 102.875%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 107.184%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 100.515%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 102.969%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 108.672%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY 112.839%
Guobang Pharma Ltd. 702.26 Million CNY 102.426%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 72.436%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY 119.656%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 103.907%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY 112.261%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY 138.571%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 103.688%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 94.867%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 108.774%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 101.575%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 108.716%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 101.895%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY 113.697%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY 109.795%
CanSino Biologics Inc. -1.93 Billion CNY 99.12%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY 109.747%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 106.146%